GT Biopharma, Inc. (GTBP) › Weighted Average Diluted SharesGT Biopharma, Inc. (GTBP) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2015-12-31: 2.39M2016-12-31: 81.5K2017-12-31: 16.8K2018-12-31: 50.2K2019-12-31: 3.38M2020-12-31: 4.39M2022-12-31: 1.06M2023-12-31: 1.35M2024-12-31: 1.90M2025-12-31: 5.51M5.51M2015-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-315.51M+190.6%2026-03-02From 2025-01-012024-12-311.90M+40.8%2026-03-02From 2024-01-012023-12-311.35M+26.9%2025-02-21From 2023-01-012022-12-311.06M—2024-03-26From 2022-01-012020-12-314.39M+29.6%2021-04-16From 2020-01-012019-12-313.38M+6635.6%2021-04-16From 2019-01-012018-12-3150.2K+199.6%2020-03-27From 2018-01-012017-12-3116.8K-79.4%2019-03-29From 2017-01-012016-12-3181.5K-96.6%2018-03-01From 2016-01-012015-12-312.39M—2018-02-28From 2015-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)